Abstract
Microbial biosynthesis of plant secondary metabolites aims to provide access to compounds of medicinal or industrial value independently of the native plant. Glucosinolates are plant secondary metabolites characteristic of brassicaceous plants and recognized as promoters of human health. However, plants often contain a complex mixture of glucosinolates with insufficient amounts to elicit a clinical effect through diet. Here, we demonstrate the biosynthesis of defined glucosinolate products in Escherichia coli through combinatorial screening of pathway enzyme homologs, tailoring the optimal biosynthetic route for each individual product. To achieve high product titers, we establish efficient P450 expression by membrane anchor truncation and engineer sulfate assimilation to increase the supply of a sulfate donor 3’-phosphoadenosine-5’-phosphosulfate. We use benzyl glucosinolate pathway as a model to test the engineering strategies and improve the titer 37-fold over our previous study. Extrapolating the best approaches to other simple glucosinolates, we establish the first microbial synthesis of tyrosine-derived p-glucosinolate. Showing the highest titer overall, we report production of 1250 ± 91 µM indolyl-3-methyl glucosinolate, a 500-fold increase over biosynthesis in yeast.
Full text
1,382 characters
· extracted from
oa-html
· click to expand
Abstract
Microbial biosynthesis of plant secondary metabolites aims to provide access to compounds of medicinal or industrial value independently of the native plant. Glucosinolates are plant secondary metabolites characteristic of brassicaceous plants and recognized as promoters of human health. However, plants often contain a complex mixture of glucosinolates with insufficient amounts to elicit a clinical effect through diet. Here, we demonstrate the biosynthesis of defined glucosinolate products in Escherichia coli through combinatorial screening of pathway enzyme homologs, tailoring the optimal biosynthetic route for each individual product. To achieve high product titers, we establish efficient P450 expression by membrane anchor truncation and engineer sulfate assimilation to increase the supply of a sulfate donor 3’-phosphoadenosine-5’-phosphosulfate. We use benzyl glucosinolate pathway as a model to test the engineering strategies and improve the titer 37-fold over our previous study. Extrapolating the best approaches to other simple glucosinolates, we establish the first microbial synthesis of tyrosine-derived p-glucosinolate. Showing the highest titer overall, we report production of 1250 ± 91 µM indolyl-3-methyl glucosinolate, a 500-fold increase over biosynthesis in yeast.
Competing Interest Statement
The authors have declared no competing interest.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.